Suppr超能文献

相似文献

1
Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma.
Clin Cancer Res. 2022 May 13;28(10):1999-2019. doi: 10.1158/1078-0432.CCR-21-3058.
2
Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma.
Am J Surg Pathol. 2023 Feb 1;47(2):183-193. doi: 10.1097/PAS.0000000000001977. Epub 2022 Oct 14.
4
Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Mod Pathol. 2022 Jan;35(Suppl 1):36-50. doi: 10.1038/s41379-021-00943-2. Epub 2021 Oct 18.
5
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
Cancer Metastasis Rev. 2023 Sep;42(3):1021-1054. doi: 10.1007/s10555-023-10121-2. Epub 2023 Jul 8.
7
Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Endocr Pathol. 2020 Sep;31(3):254-263. doi: 10.1007/s12022-020-09626-1.

引用本文的文献

6
Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?
Endocr Pathol. 2024 Jun;35(2):91-106. doi: 10.1007/s12022-024-09807-2. Epub 2024 Mar 12.
7
New clinical trial design in precision medicine: discovery, development and direction.
Signal Transduct Target Ther. 2024 Mar 4;9(1):57. doi: 10.1038/s41392-024-01760-0.
8
Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?
Front Endocrinol (Lausanne). 2023 Oct 16;14:1248575. doi: 10.3389/fendo.2023.1248575. eCollection 2023.
9
Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma.
Cancers (Basel). 2023 Oct 11;15(20):4951. doi: 10.3390/cancers15204951.
10
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment.
Curr Oncol Rep. 2023 Oct;25(10):1127-1139. doi: 10.1007/s11912-023-01438-w. Epub 2023 Aug 22.

本文引用的文献

1
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity.
Nat Cancer. 2020 Apr;1(4):437-451. doi: 10.1038/s43018-020-0046-2. Epub 2020 Apr 13.
2
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Endocr Relat Cancer. 2021 Nov 11;29(1):1-14. doi: 10.1530/ERC-21-0152.
3
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors.
Curr Oncol Rep. 2021 Jul 16;23(9):100. doi: 10.1007/s11912-021-01099-7.
4
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
Mod Pathol. 2021 Nov;34(11):1979-1989. doi: 10.1038/s41379-021-00869-9. Epub 2021 Jul 10.
6
The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Gynecol Oncol. 2021 Jun;161(3):779-786. doi: 10.1016/j.ygyno.2021.04.019. Epub 2021 May 1.
7
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.
Cancer Cell. 2021 Apr 12;39(4):566-579.e7. doi: 10.1016/j.ccell.2021.02.014.
8
Predictive biomarkers for response to immune checkpoint inhibition.
Semin Cancer Biol. 2022 Feb;79:4-17. doi: 10.1016/j.semcancer.2021.03.036. Epub 2021 Apr 2.
9
The Next Decade of Immune Checkpoint Therapy.
Cancer Discov. 2021 Apr;11(4):838-857. doi: 10.1158/2159-8290.CD-20-1680.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验